ISO 10993-7-2026 Biological evaluation of medicaldevices-Part 7Ethylene oxide sterilizationresiduals
VIP免费
Biological evaluation of medical
devices —
Part 7:
Ethylene oxide sterilization
residuals
Évaluation biologique des dispositifs médicaux —
Partie 7: Résidus de stérilisation à l'oxyde d'éthylène
International
Standard
ISO 10993-7
Third edition
2026-04
Reference number
ISO 10993-7:2026(en) © ISO 2026
(103.27.9.24) VALID UPTO 3/20/2027 11:59:00 PM
ii
ISO 10993-7:2026(en)
© ISO 2026 – All rights reserved
COPYRIGHT PROTECTED DOCUMENT
© ISO 2026
CP 401 • Ch. de Blandonnet 8
Phone: +41 22 749 01 11
www.iso.org
(103.27.9.24) VALID UPTO 3/20/2027 11:59:00 PM
ISO 10993-7:2026(en)
Foreword ....................................................................................................................................................................................................................................................iv
Introduction .............................................................................................................................................................................................................................................v
1 Scope ............................................................................................................................................................................................................................................. 1
2 Normative references ................................................................................................................................................................................................. 1
................................................................................................................................................................................................ 1
4 Requirements ...................................................................................................................................................................................................................... 5
........................................................................................................................................... ............................................................................. 5
...........................................................................................................................................................................6
.................................................................................................................................................................................................. 6
.....................................................................................................................................................................................................6
.......................................................................................................................................................8
.................................................................................................................................................9
................................................................................................................................................9
.........................................................................................................................................................................11
............................................................................................................................................................ 12
................................................................................................................................... 12
.......................................................................................................................................................................................... 12
.......................................................................................................................................................... 12
........................................................................................................................................................................ 12
.................................................................................................................................................................... 13
..................................................................................................................................................................... 13
............................................................................................................................................................... 13
5 Product release .............................................................................................................................................................................................................. 13
......... ........................................................................................................................................................................................................... 13
........................................................................................................................................................................14
.........................................................................................14
......................................................................14
6 Adoption of products into established aeration family ......................................................................................................15
7 Change evaluation ....................................................................................................................................................................................................... 15
Annex A Guidance for the application of this document for the determination of
EO and ECH residuals in medical devices ........................................................................................................................................... 16
Annex B ......................................................................................................... 27
Annex C Rationale for the provisions of this document ....................................................................................30
Annex D Establishment of allowable limits for EO .................................................................................................. 38
Annex E Establishment of allowable limits for ECH ............................................................................................... 56
Annex F Ethylene glycol........................................................................................................................................................................66
Annex G Evaluation of gas chromatograms ........................................................................................................................ 70
Annex H Gas chromatographic determination for EO and ECH ................................................................. 74
Annex I Preparation of EO and ECH standards ...........................................................................................................78
Annex J Ethylene oxide and ethylene chlorohydrin residual measuring methods ..............82
Annex K Examples of product release methods .........................................................................................................90
Bibliography ...................................................................................................................................................................................................................................... 109
iii
© ISO 2026 – All rights reserved
Contents Page
(103.27.9.24) VALID UPTO 3/20/2027 11:59:00 PM
摘要:
展开>>
收起<<
Biologicalevaluationofmedicaldevices—Part7:EthyleneoxidesterilizationresidualsÉvaluationbiologiquedesdispositifsmédicaux—Partie7:Résidusdestérilisationàl'oxyded'éthylèneInternationalStandardISO10993-7Thirdedition2026-04ReferencenumberISO10993-7:2026(en)©ISO2026(103.27.9.24)VALIDUPTO3/20/202711:59:00...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
GB∕T 25915.2-2021 洁净室及相关受控环境 第2部分:洁净室空气粒子浓度的监测
2024-04-17 999+ -
GB∕T 25915.3-2024洁净室及相关受控环境 第3部分:检测方法VIP免费
2024-08-09 127 -
(高清)GB∕T 25915.3-2024 洁净室及相关受控环境第3部分:检测方法VIP免费
2025-08-27 999+ -
GB∕T 16886.1-2025医疗器械生物学评价 第1部分 风险管理过程中生物学安全性评价的要求和通用原则(草案稿)VIP免费
2025-09-02 833 -
GB∕T 16886.11-2021 医疗器械生物学评价 第11部分:全身毒性试验VIP免费
2025-09-02 865 -
GB∕T 191-2025 包装储运图示标志(征求意见稿)VIP免费
2025-09-29 999+ -
GB∕T 19000-2016 质量管理体系 基础和术语(高清)VIP免费
2025-10-27 999+ -
GB∕T 19001-2016 质量管理体系要求
2025-10-27 999+ -
GB∕T 16292-2025 医药工业洁净室(区)悬浮粒子的测试方法VIP免费
2025-10-29 999+ -
GB∕T 16292《医药工业洁净室(区)悬浮粒子的测试方法》2010版和2025版对比分析(逐条对比)VIP免费
2025-10-30 579
作者:雨尘yc
分类:法规规范
价格:150质量币
属性:128 页
大小:4.97MB
格式:PDF
时间:2026-05-14

